Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001038396 | SCV001201863 | benign | Tuberous sclerosis 2 | 2023-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307814 | SCV004001450 | likely benign | Hereditary cancer-predisposing syndrome | 2023-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Neuberg Centre For Genomic Medicine, |
RCV001038396 | SCV005382424 | uncertain significance | Tuberous sclerosis 2 | 2023-05-20 | criteria provided, single submitter | clinical testing | The observed missense c.4279A>G (p.Ser1427Gly) variant in TSC2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Ser1427Gly variant is present with allele frequency of 0.001% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Uncertain Significance. The reference amino acid of p.Ser1427Gly in TSC2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Ser at position 1427 is changed to a Gly changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as a Variant of Uncertain Significance (VUS). |